On Oct. 22, Walmart shared its plan to become the first retailer to offer combined delivery of pharmacy and general merchandise online orders. 

In the first six months of 2024, the Inflation Reduction Act has saved 1.5 million Medicare Part D enrollees nearly $1 billion in out-of-pocket prescription drug costs, HHS said Oct. 22. 

A total of $66.3 billion in outpatient drugs was purchased through the 340B drug pricing program in 2023, according to data from the Health Resources and Services Administration released Oct. 21. 

Workers at seven CVS pharmacies in Southern California have gone on strike, demanding better pay, improved healthcare and protesting what they say are bad-faith negotiations, the Los Angeles Times reported Oct. 20. 

In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21. 

A study found that the blaNDM gene, associated with multidrug-resistant infections, was widely detected in antibiotic-resistant infections in patients at New Hyde Park, N.Y.-based Northwell Health. 

A recent study found a correlation between stock market downturns and rising antidepressant prescriptions. 

More than 55% of patients taking Elahere, an ovarian cancer approved in 2022, may experience vision loss, according to a new study. 

The shortage of pediatric cancer drugs is a growing concern for families and healthcare providers, with critical medications, like injectable methotrexate and leucovrin, increasingly hard to obtain for children diagnosed with leukemia, USA Today reported Oct. 17. 

The FDA has placed a clinical hold on Novavax's  application for its COVID-19-Influenza combination and standalone influenza vaccine candidates following a report of a "serious adverse event."